This inventor holds 7 USPTO granted patents, plus 2 CIPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 1984-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984-1999
Title: Innovations by Jozef Frans Van Gestel in Antibacterial and Antifouling Agents
Introduction
Jozef Frans Van Gestel, an esteemed inventor based in Vosselaar, Belgium, has made a significant impact in the realm of innovations. With a total of seven patents to his name, he has dedicated his expertise to developing novel solutions for various applications.
Latest Patents
His most recent patents focus on the development of antibacterial and antifouling oxathiazines and their oxides. These compounds, described with a complex formula involving 3-aryl-5,6-dihydro-1,4,2-oxathiazines, exhibit properties that enable their use as antibacterial, anti-yeast, antifungal, algicidal, anticrustacean, molluscicidal, and general antifouling agents. This innovation holds promise for enhancing biocidal applications in several industries.
Career Highlights
Jozef works for Janssen Pharmaceutica NV, a prominent pharmaceutical company recognized for its advancements in drug development and innovation. His contributions to the field of chemistry and pharmacology reflect his commitment to addressing critical health and environmental challenges through his inventions.
Collaborations
Throughout his career, Jozef has collaborated with notable colleagues, including William R. Lutz and Guy Rosalia Van Lommen. Their joint efforts highlight the importance of teamwork and collaboration in the research and development of groundbreaking technologies.
Conclusion
Jozef Frans Van Gestel's innovative contributions to the field of antibacterial and antifouling agents pave the way for future advancements in therapeutics and preventive strategies against microbial contamination. His patents represent not only personal achievements but also significant progress in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
